Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Inspyr Therapeutics
Inspyr Therapeutics develops targeted cancer therapeutics for various types of tumors.
Sector
Subsector
Location
total rounds
total raised
G1 Therapeutics
G1 Therapeutics is a clinical-stage company developing novel cancer therapies.
Sector
Subsector
Keywords
Location
total rounds
total raised
Samus Therapeutics
Samus Therapeutics is developing novel therapeutics targeting the epichaperome.
Sector
Subsector
Keywords
Location
Sapience Therapeutics
Sapience Therapeutics is a preclinical-stage biotech company developing novel therapeutics for cancer.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds10
Number of Funding Rounds
Money Raised
Their latest funding was raised on 10.04.2024. Their latest investor Gilead Sciences. Their latest round Post-IPO Equity
Co-Investors
Investors10
Number of lead investors
Number of investors
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that develops and commercializes innovative medicines.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
683 CAPITAL
683 CAPITAL MANAGEMENT is a hedge fund.
Sector
Subsector
Keywords
count Of Investments
Samsara BioCapital
Samsara BioCapital is a Palo Alto-based venture capital firm specializing in life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
Acquisitions2
Flame Biosciences acquired by Leap Therapeutics
acquirer
date
Flame Biosciences
Flame Biosciences develops value-added medicines in the emerging area of inflammasome science.
Sector
Subsector
Keywords
Location
total rounds
total raised
MacroCure acquired by Leap Therapeutics
acquirer
date
type
MacroCure
MacroCure is a biopharmaceutical company that develops and commercializes advanced cell therapy products.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders1
Douglas E. Onsi
Mr. Onsi has served as our Chief Financial Officer, Treasurer and Secretary since our inception in 2011. Mr. Onsi has been at HealthCare Ventures since 2007, including serving as a managing director since 2009 and the chief executive officer of Tensha Therapeutics, Inc. which was sold to Roche Holdings, Inc. in 2016. Prior to joining HealthCare Ventures, Mr. Onsi was at Genzyme Corporation, or Genzyme, where he served in roles as Vice President, Campath Product Operations and Portfolio Management, Oncology from 2005 to 2007 and as Vice President, Business Development from 2004 to 2005. Prior to Genzyme, he was Chief Financial Officer of Tolerx, Inc., a venture capital funded biotechnology company, from 2001 to 2004. Before joining Tolerx, Inc., he was in business development at LeukoSite, a publicly traded biopharmaceutical company that was acquired by Millennium Pharmaceuticals, Inc. He began his career as an attorney at Bingham Dana LLP. Mr. Onsi currently serves as a member of the board of directors of Vaxxas Pty Ltd., a privately-held biotechnology company. He received a Juris Doctor degree from the University of Michigan Law School and a B.S. in biological sciences from Cornell University.
current job
Douglas E. Onsi
Employee Profiles8
Jonathan Miller
Associate director, financial planning and analysis
Activity
Recent News7
The graph reveals the ratio (%) of positive news articles in a chosen time range